Psoriatic arthritis

Guidelines (ACR/EULAR/GRAPPA) for the management of psoriatic arthritis (PsA) recommend the early referral of patients with the suspected condition for early assessment and treatment. There remains a…

The RheumNow faculty reporters have been scouring the meeting for what they believe to be the best presentations from the first day at ACR 2023 in San Diego.  From hundreds of online…

The following is a true account of this morning and every other morning I can remember.  The first one to greet me when I wake up is our cat. As a matter of fact, he’s the one who typically…

As rheumatologists, we are medical detectives investigating complex and often elusive autoimmune and inflammatory conditions. Patients expect us to be the experts who understand their disease, give…

Of the many exciting advancements for patients with psoriatic arthritis at ACR Convergence, one upcoming therapy stood out: the dual IL-17A/F inhibitor bimekizumab. Nearly two dozen bimekizumab…

In clinical practice, pulmonary manifestations of rheumatic medical diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and peripheral spondyloarthritis (pSpA) are typically not…

Dr. Jack Cush discusses the news, journal articles and regulatory actions. This week we discuss JAKne, DLE and SLE and more. was associated with an elevated odds of acne (OR 3-5 for UPA, TOFA,…